Singapore markets closed

OncoTherapy Science Inc (30O.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.0835+0.0015 (+1.83%)
At close: 08:04AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
901,220
1,134,903
1,153,663
332,477
Cost of revenue
982,582
1,093,218
1,039,751
312,935
Gross profit
-81,362
41,685
113,912
19,542
Operating expenses
Research development
693,232
716,463
1,730,270
1,375,683
Selling general and administrative
399,625
431,637
436,279
281,795
Total operating expenses
1,092,857
1,148,100
2,166,549
1,657,478
Operating income or loss
-1,174,219
-1,106,415
-2,052,637
-1,637,936
Income before tax
-1,190,362
-1,116,420
-2,570,306
-1,560,012
Income tax expense
2,412
2,223
1,234
1,623
Income from continuing operations
-1,192,774
-1,118,643
-2,571,540
-1,561,635
Net income
-1,192,776
-1,118,644
-2,571,541
-1,561,636
Net income available to common shareholders
-1,192,776
-1,118,644
-2,571,541
-1,561,636
Basic EPS
-6.04
-5.81
-13.72
-8.86
Diluted EPS
-6.04
-5.81
-13.72
-8.86
Basic average shares
200,258
192,644
187,466
176,332
Diluted average shares
217,644
192,644
187,466
176,332